- Home
- AVTX vs DTSQ Comparison
AVTX vs DTSQ Comparison
Compare AVTX & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- DTSQ
- Stock Information
- Founded
- AVTX 2011
- DTSQ 2022
- Country
- AVTX United States
- DTSQ United States
- Employees
- AVTX N/A
- DTSQ N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- DTSQ
- Sector
- AVTX Health Care
- DTSQ
- Exchange
- AVTX Nasdaq
- DTSQ NYSE
- Market Cap
- AVTX 88.4M
- DTSQ 89.8M
- IPO Year
- AVTX 2015
- DTSQ 2024
- Fundamental
- Price
- AVTX $8.44
- DTSQ $10.15
- Analyst Decision
- AVTX Strong Buy
- DTSQ
- Analyst Count
- AVTX 4
- DTSQ 0
- Target Price
- AVTX $33.00
- DTSQ N/A
- AVG Volume (30 Days)
- AVTX 36.6K
- DTSQ 63.9K
- Earning Date
- AVTX 03-28-2025
- DTSQ 01-01-0001
- Dividend Yield
- AVTX N/A
- DTSQ N/A
- EPS Growth
- AVTX N/A
- DTSQ N/A
- EPS
- AVTX N/A
- DTSQ 0.17
- Revenue
- AVTX $820,000.00
- DTSQ N/A
- Revenue This Year
- AVTX N/A
- DTSQ N/A
- Revenue Next Year
- AVTX N/A
- DTSQ N/A
- P/E Ratio
- AVTX N/A
- DTSQ $61.02
- Revenue Growth
- AVTX N/A
- DTSQ N/A
- 52 Week Low
- AVTX $4.24
- DTSQ $9.96
- 52 Week High
- AVTX $34.46
- DTSQ $10.17
- Technical
- Relative Strength Index (RSI)
- AVTX 57.77
- DTSQ N/A
- Support Level
- AVTX $6.81
- DTSQ N/A
- Resistance Level
- AVTX $8.00
- DTSQ N/A
- Average True Range (ATR)
- AVTX 0.56
- DTSQ 0.00
- MACD
- AVTX 0.03
- DTSQ 0.00
- Stochastic Oscillator
- AVTX 81.99
- DTSQ 0.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.